Robert W. Ross
2018
In 2018, Robert W. Ross earned a total compensation of $880K as Chief Medical Officer at Surface Oncology, a 88% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $123,900 |
|---|---|
| Option Awards | $384,963 |
| Salary | $361,000 |
| Other | $10,115 |
| Total | $879,978 |
Ross received $385K in option awards, accounting for 44% of the total pay in 2018.
Ross also received $123.9K in non-equity incentive plan, $361K in salary and $10.1K in other compensation.
Rankings
In 2018, Robert W. Ross' compensation ranked 9,784th out of 14,244 executives tracked by ExecPay. In other words, Ross earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,784 out of 14,244 | 31st |
Division Manufacturing | 3,949 out of 5,765 | 32nd |
Major group Chemicals And Allied Products | 1,483 out of 2,128 | 30th |
Industry group Drugs | 1,250 out of 1,817 | 31st |
Industry Biological Products, Except Diagnostic Substances | 247 out of 339 | 27th |
Source: SEC filing on April 19, 2019.
Ross' colleagues
We found two more compensation records of executives who worked with Robert W. Ross at Surface Oncology in 2018.